Analyst Reco. Encompass Health Corporation

Equities

EHC

US29261A1007

Market Closed - Nyse Other stock markets 04:00:02 2024-06-07 pm EDT			5-day change	1st Jan Change
84.85 ^USD	-0.49%		-1.78%	+27.17%

May. 30	Transcript : Encompass Health Corporation Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 08:00 AM
May. 24	Encompass Health Insider Sold Shares Worth $850,200, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Encompass Health Insider Sold Shares Worth $850,200, According to a Recent SEC Filing	May. 24	MT
RBC Lifts Price Target on Encompass Health to $95 From $83, Cites 'Strong' Q1 Results, 2024 Guidance Boost; Outperform Kept	May. 22	MT
Encompass Health Insider Sold Shares Worth $1,220,739, According to a Recent SEC Filing	May. 07	MT
Encompass Health Insider Sold Shares Worth $3,745,152, According to a Recent SEC Filing	May. 01	MT
UBS Adjusts Encompass Health Price Target to $96 From $88, Maintains Buy Rating	Apr. 29	MT
Mizuho Adjusts Price Target on Encompass Health to $95 From $93, Keeps Buy Rating	Apr. 25	MT
Barclays Raises Price Target on Encompass Health to $101 From $95, Maintains Overweight Rating	Mar. 28	MT
UBS Adjusts Encompass Health Price Target to $88 From $84, Maintains Buy Rating	Feb. 09	MT
Mizuho Raises Price Target on Encompass Health to $82 From $77, Keeps Buy Rating	Feb. 09	MT
Deutsche Bank Adjusts Encompass Health Price Target to $83 From $77, Maintains Buy Rating	Feb. 09	MT
RBC Raises Price Target on Encompass Health to $83 From $70, Cites 'Impressive Beat,' Guidance Boost; Outperform Kept	23-08-08	MT
Credit Suisse Adjusts Encompass Health's Price Target to $80 From $76, Keeps Outperform Rating	23-08-04	MT
Deutsche Bank Adjusts Encompass Health Price Target to $77 From $73, Maintains Buy Rating	23-08-03	MT
Truist Securities Adjusts Price Target on Encompass Health to $82 From $75, Maintains Buy Rating	23-08-03	MT
Mizuho Adjusts Price Target on Encompass Health to $77 From $74, Maintains Buy Rating	23-08-03	MT
Barclays Adjusts Price Target on Encompass Health to $71 From $61, Maintains Equal-Weight Rating	23-08-03	MT
UBS Adjusts Encompass Health Price Target to $84 From $77, Maintains Buy Rating	23-08-02	MT
Stephens Adjusts Price Target on Encompass Health to $78 From $74, Maintains Overweight Rating	23-06-29	MT
Raymond James Raises Price Target on Encompass Health to $80 From $72, Maintains Strong Buy Rating	23-05-02	MT
RBC Boosts Price Target on Encompass Health to $70 From $66, Maintains Outperform Rating	23-05-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Encompass Health Corporation

Equities

EHC

US29261A1007

Analyst Reco.

Filters